An autoantibody to GAD65 in sera of patients with juvenile neuronal ceroid lipofuscinoses.

scientific article published in December 2002

An autoantibody to GAD65 in sera of patients with juvenile neuronal ceroid lipofuscinoses. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1212/01.WNL.0000041913.97883.8B
P698PubMed publication ID12473787

P2093author name stringDavid A Pearce
Subrata Chattopadhyay
David A Wenger
Elizabeth Kriscenski-Perry
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectautoantibodyQ785022
P304page(s)1816-1817
P577publication date2002-12-01
P1433published inNeurologyQ1161692
P1476titleAn autoantibody to GAD65 in sera of patients with juvenile neuronal ceroid lipofuscinoses.
P478volume59

Reverse relations

cites work (P2860)
Q36986268Antigen presenting cell abnormalities in the Cln3(-/-) mouse model of juvenile neuronal ceroid lipofuscinosis
Q50056608Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy.
Q90400660Combined Anti-inflammatory and Neuroprotective Treatments Have the Potential to Impact Disease Phenotypes in Cln3 -/- Mice
Q48421299Distinct patterns of serum immunoreactivity as evidence for multiple brain-directed autoantibodies in juvenile neuronal ceroid lipofuscinosis
Q34719788High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome
Q33814536High levels of Anti-GAD65 and Anti-Ro52 autoantibodies in a patient with major depressive disorder showing psychomotor disturbance
Q34142898Immunosuppression alters disease severity in juvenile Batten disease mice
Q46578546Proteolytic degradation of glutamate decarboxylase mediates disinhibition of hippocampal CA3 pyramidal cells in cathepsin D-deficient mice.
Q35681068Selectivity and types of cell death in the neuronal ceroid lipofuscinoses
Q64044847Short-Term Administration of Mycophenolate Is Well-Tolerated in CLN3 Disease (Juvenile Neuronal Ceroid Lipofuscinosis)
Q64040442Therapeutic landscape for Batten disease: current treatments and future prospects
Q37260497Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease)

Search more.